StimAire Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$450K
- Investors
-
5
StimAire General Information
Description
Developer of an injectable neuromodulation device designed to create a patient-friendly alternative for healthy sleep. The company's technology also has the potential to treat bladder urgency, gastrointestinal diseases, autoimmune disorders, depression, pain, and cluster headaches, enabling medical practitioners to eliminate major surgery and hospital stays for patients.
Contact Information
Website
www.stimaire.comCorporate Office
- Santa Clarita, CA
- United States
Corporate Office
- Santa Clarita, CA
- United States
StimAire Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 05-Jun-2024 | $450K | In Progress | Pre-Clinical Trials | ||
| 3. Early Stage VC (Series A) | 01-Nov-2019 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 11-Apr-2018 | $340K | $340K | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Pre-Clinical Trials |
StimAire Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
StimAire Patents
StimAire Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021218682-A1 | Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications | Active | 11-Feb-2020 | ||
| AU-2021218682-B2 | Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications | Active | 11-Feb-2020 | ||
| CA-3166004-A1 | Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications | Pending | 11-Feb-2020 | ||
| EP-4103261-A1 | Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications | Active | 11-Feb-2020 | ||
| EP-4103261-A4 | Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications | Active | 11-Feb-2020 | H02J50/12 |
StimAire Signals
StimAire Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Desert Angels | Angel Group | Minority | ||
| Maverick Angels | Angel Group | Minority | ||
| UAVenture Capital | Venture Capital | Minority | ||
| AngelMD | Angel Group | Minority | ||
| University of Arizona | University |
StimAire FAQs
-
When was StimAire founded?
StimAire was founded in 2017.
-
Where is StimAire headquartered?
StimAire is headquartered in Santa Clarita, CA.
-
What is the size of StimAire?
StimAire has 5 total employees.
-
What industry is StimAire in?
StimAire’s primary industry is Therapeutic Devices.
-
Is StimAire a private or public company?
StimAire is a Private company.
-
What is StimAire’s current revenue?
The current revenue for StimAire is .
-
How much funding has StimAire raised over time?
StimAire has raised $2.34M.
-
Who are StimAire’s investors?
Desert Angels, Maverick Angels, UAVenture Capital, AngelMD, and University of Arizona have invested in StimAire.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process